(VIANEWS) – Realty Income Corporation (O), Amgen (AMGN), Perion Network Ltd (PERI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Realty Income Corporation (O)
29% sales growth and 3.02% return on equity
Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 13,250 real estate properties primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 640 consecutive monthly dividends on its shares of common stock throughout its 54-year operating history and increased the dividend 122 times since Realty Income's public listing in 1994 (NYSE: O).
Earnings Per Share
As for profitability, Realty Income Corporation has a trailing twelve months EPS of $1.32.
PE Ratio
Realty Income Corporation has a trailing twelve months price to earnings ratio of 41.19. Meaning, the purchaser of the share is investing $41.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.02%.
2. Amgen (AMGN)
23.6% sales growth and 133.8% return on equity
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Earnings Per Share
As for profitability, Amgen has a trailing twelve months EPS of $14.06.
PE Ratio
Amgen has a trailing twelve months price to earnings ratio of 23.05. Meaning, the purchaser of the share is investing $23.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 133.8%.
Previous days news about Amgen(AMGN)
- According to Zacks on Friday, 2 February, "Last year, Amgen (AMGN Quick QuoteAMGN – Free Report) launched the first Humira biosimilar in the United States, called Amjevita.", "Like Amgen and Sandoz, more generic drugmakers are planning to launch their own Humira biosimilars. "
3. Perion Network Ltd (PERI)
20.4% sales growth and 19.25% return on equity
Perion Network Ltd. provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally. It provides Wildfire, a content monetization platform; search monetization solutions, including website monetization, search mediation, and app monetization; and cross-channel digital advertising software as a service platform. The company also offers supply management platform; demand management platform for campaign planning and design; analytics platform, which provides information and performance insights on the results of campaign investment and other campaign metrics; creative platform to create advertisements; and an AI platform that uses machine learning to bring intelligence to the various phases of campaigns. In addition, it provides an actionable performance monitoring platform to support the various phases of campaign management; an online video player and integrated ad server to upload, manage, and stream video content; content monetization system, which integrates ads within the content layouts at the page level. Further, the company offers a publisher management system that provides analytics and performance optimization tools, as well as reports; search-demand management systems; monetization products that integrate and onboards demand vendors; and AI Systems. Additionally, it provides Intelligent HUB (iHUB), a platform for pulling in signals across various advertising channels and optimizing traffic at scale, and yielding engagement metrics and KPIs; and strategic optimization of relevant traits (SORT), a provisional patent technology that eliminates the need for cookies. The company was formerly known as IncrediMail Ltd. and changed its name to Perion Network Ltd. in November 2011. Perion Network Ltd. was incorporated in 1999 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Perion Network Ltd has a trailing twelve months EPS of $2.36.
PE Ratio
Perion Network Ltd has a trailing twelve months price to earnings ratio of 12.44. Meaning, the purchaser of the share is investing $12.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.25%.
Sales Growth
Perion Network Ltd’s sales growth is 11.2% for the present quarter and 20.4% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 3.8% and a drop 2.1% for the next.
4. EastGroup Properties (EGP)
14.4% sales growth and 8.04% return on equity
EastGroup Properties, Inc. (NYSE: EGP), an S&P MidCap 400 company, is a self-administered equity real estate investment trust focused on the development, acquisition and operation of industrial properties in major Sunbelt markets throughout the United States with an emphasis in the states of Florida, Texas, Arizona, California and North Carolina. The Company's goal is to maximize shareholder value by being a leading provider in its markets of functional, flexible and quality business distribution space for location sensitive customers (primarily in the 15,000 to 70,000 square foot range). The Company's strategy for growth is based on ownership of premier distribution facilities generally clustered near major transportation features in supply-constrained submarkets. EastGroup's portfolio, including development projects and value-add acquisitions in lease-up and under construction, currently includes approximately 45.7 million square feet.
Earnings Per Share
As for profitability, EastGroup Properties has a trailing twelve months EPS of $3.94.
PE Ratio
EastGroup Properties has a trailing twelve months price to earnings ratio of 46.12. Meaning, the purchaser of the share is investing $46.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.04%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 20.2% and 5.9%, respectively.
Moving Average
EastGroup Properties’s value is above its 50-day moving average of $177.48 and higher than its 200-day moving average of $172.42.
Volume
Today’s last reported volume for EastGroup Properties is 207318 which is 34.95% below its average volume of 318745.
5. Graham Holdings Company (GHC)
14.3% sales growth and 4.02% return on equity
Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally. It provides test preparation services and materials; professional training and exam preparation for professional certifications and licensures; and non-academic operations support services to the Purdue University Global; operations support services for online courses and programs; training and test preparation services for accounting and financial services professionals; English-language training, academic preparation programs, and test preparation for English proficiency exams; and A-level examination preparation services, as well as operates colleges, business school, higher education institution, and an online learning institution. The company also owns and operates television stations, restaurants, and entertainment venues; engages in the financial training and automobile dealerships business; offers social media management tools to connect newsrooms with their users; produces Foreign Policy magazine and ForeignPolicy.com website; and publishes Slate, an online magazine, as well as French-language news magazine websites at slate.fr and slateafrique.com. In addition, it provides social media marketing solutions; home health, hospice, and palliative services; burners, igniters, dampers, and controls; screw jacks, linear actuators, and related linear motion products, and lifting systems; pressure impregnated kiln-dried lumber and plywood products; digital advertising services; power charging and data systems, industrial and commercial indoor lighting solutions, and electrical components and assemblies; dermatology and professional aesthetics, and skin care services; software and services; and operates pharmacy. The company was formerly known as The Washington Post Company and changed its name to Graham Holdings Company in November 2013. Graham Holdings Company was founded in 1877 and is based in Arlington, Virginia.
Earnings Per Share
As for profitability, Graham Holdings Company has a trailing twelve months EPS of $33.48.
PE Ratio
Graham Holdings Company has a trailing twelve months price to earnings ratio of 21.07. Meaning, the purchaser of the share is investing $21.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.02%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 33.4% and positive 32.1% for the next.
Moving Average
Graham Holdings Company’s value is higher than its 50-day moving average of $679.44 and way above its 200-day moving average of $607.03.
6. Ares Capital (ARCC)
9.9% sales growth and 12.67% return on equity
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $2.31.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 8.75. Meaning, the purchaser of the share is investing $8.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.67%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 9.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22%, now sitting on 2.55B for the twelve trailing months.
Previous days news about Ares Capital(ARCC)
- Stay ahead of the game with ares capital (arcc) Q4 earnings: wall street's insights on key metrics. According to Zacks on Friday, 2 February, "Given this perspective, it’s time to examine the average forecasts of specific Ares Capital metrics that are routinely monitored and predicted by Wall Street analysts.", "In its upcoming report, Ares Capital (ARCC Quick QuoteARCC – Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.59 per share, reflecting a decline of 6.4% compared to the same period last year. "
7. American National Bankshares (AMNB)
9% sales growth and 7.87% return on equity
American National Bankshares Inc. operates as the bank holding company for American National Bank and Trust Company that provides financial products and services in Virginia and North Carolina. The company operates through two segments, Community Banking, and Trust and Investment Services. It accepts deposit products, including checking, money market, savings, and consumer and commercial time deposits, as well as certificates of deposit. The company's loan products comprise commercial and residential real estate loans, commercial loans to small and medium-sized businesses, construction and land development loans, home equity loans, mortgage loans, and consumer loans. It also offers trust and investment services, such as estate planning, trust account administration, and retail brokerage services; online and telephone banking services; insurance services; and investment management services, including purchasing equity, fixed income, and mutual fund investments for customer accounts, as well as operates 37 automated teller machines. As of December 31, 2020, it operated 26 banking offices; and one loan production offices in Roanoke, Virginia. American National Bankshares Inc. was founded in 1909 and is headquartered in Danville, Virginia.
Earnings Per Share
As for profitability, American National Bankshares has a trailing twelve months EPS of $2.46.
PE Ratio
American National Bankshares has a trailing twelve months price to earnings ratio of 19.34. Meaning, the purchaser of the share is investing $19.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.
Sales Growth
American National Bankshares’s sales growth is negative 0.7% for the current quarter and 9% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 2.52%.
8. Canadian Pacific Railway (CP)
8.8% sales growth and 9.65% return on equity
Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada and the United States. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; and merchandise freight, such as energy, chemicals and plastics, metals, minerals and consumer, automotive, and forest products. It transports intermodal traffic comprising retail goods in overseas containers. The company offers rail and intermodal transportation services through a network of approximately 13,000 miles serving business centers in Quebec and British Columbia, Canada; and the United States Northeast and Midwest regions. Canadian Pacific Kansas City Limited is headquartered in Calgary, Canada.
Earnings Per Share
As for profitability, Canadian Pacific Railway has a trailing twelve months EPS of $3.14.
PE Ratio
Canadian Pacific Railway has a trailing twelve months price to earnings ratio of 26.53. Meaning, the purchaser of the share is investing $26.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.65%.
Moving Average
Canadian Pacific Railway’s value is higher than its 50-day moving average of $76.70 and higher than its 200-day moving average of $77.34.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 5.9% and 21%, respectively.
